101 related articles for article (PubMed ID: 9586617)
1. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
Rehman J; Benet A; Melman A
Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
Alizadeh M; Karimi F; Fallah MR
Glob J Health Sci; 2014 Sep; 6(7 Spec No):23-30. PubMed ID: 25363175
[TBL] [Abstract][Full Text] [Related]
3. Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease.
Dell'Atti L
Urol Ann; 2015; 7(3):345-9. PubMed ID: 26229323
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological therapy in patients diagnosed with Peyronie's disease.
Halal AA; Geavlete P; Ceban E
J Med Life; 2012 Jun; 5(2):192-5. PubMed ID: 22802890
[TBL] [Abstract][Full Text] [Related]
5. Safety and feasibility of percutaneous needle tunneling with platelet-rich plasma injections for Peyronie's disease in the outpatient setting: a pilot study.
Zugail AS; Alshuaibi M; Lombion S; Beley S
Int J Impot Res; 2024 Apr; 36(2):140-145. PubMed ID: 37550385
[TBL] [Abstract][Full Text] [Related]
6. Multimodal treatments based on Tadalafil during acute phase of Peyronie's disease: experience at two referral academic centers.
Dell'Atti L; Slyusar V; Cambise C
Ir J Med Sci; 2024 Jun; ():. PubMed ID: 38861101
[TBL] [Abstract][Full Text] [Related]
7. Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie's Disease.
Kokab A; Wylie K; Allen P; Shetty A; Davies-South D
Adv Urol; 2014; 2014():957013. PubMed ID: 24803927
[TBL] [Abstract][Full Text] [Related]
8. Treatment Trends and Cost Associated With Peyronie's Disease.
Loftus CJ; Rajanahally S; Holt SK; Raheem OA; Ostrowski KA; Walsh TJ
Sex Med; 2020 Dec; 8(4):673-678. PubMed ID: 33036960
[TBL] [Abstract][Full Text] [Related]
9. Unveiling treatment horizons and contemporary perspectives in Peyronie's disease - take home messages from Laurance A. Levine special issue.
Levine LA
Int J Impot Res; 2024 Apr; 36(2):173-174. PubMed ID: 38374210
[No Abstract] [Full Text] [Related]
10. Response to the Commentary on: Safety and feasibility of percutaneous needle tunneling with platelet-rich plasma injections for Peyronie's disease in the outpatient setting: a pilot study.
Zugail AS; Alshuaibi M; Beley S
Int J Impot Res; 2024 May; 36(3):299-300. PubMed ID: 38580726
[No Abstract] [Full Text] [Related]
11. An irregular plaque of the penile base.
Uppal E; Kravvas G; Freeman A; Proctor I; Lofaro T; Alnajjar H; Muneer A; Bunker CB
Clin Exp Dermatol; 2024 Jun; ():. PubMed ID: 38889228
[No Abstract] [Full Text] [Related]
12. Non-surgical therapies for Peyronie's disease.
Rosenberg JE; Ergun O; Hwang EC; Risk MC; Jung JH; Edwards ME; Blair Y; Dahm P
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD012206. PubMed ID: 37490423
[TBL] [Abstract][Full Text] [Related]
13. A Case Report of Bilateral Plantar Fibromatosis and Review of Treatment Options.
Zachariou D; Rozis M; Galanis A; Vlachos C; Vavourakis M; Vasiliadis E; Pneumaticos S
Maedica (Bucur); 2023 Mar; 18(1):136-142. PubMed ID: 37266461
[TBL] [Abstract][Full Text] [Related]
14. Peyronie's Disease: An Outcomes-Based Guide to Non-Surgical and Novel Treatment Modalities.
Reddy AG; Dai MC; Song JJ; Pierce HM; Patel SR; Lipshultz LI
Res Rep Urol; 2023; 15():55-67. PubMed ID: 36756281
[TBL] [Abstract][Full Text] [Related]
15. The Immunological Microenvironment and the Emerging Role of Stem Cells Therapy in Peyronie's Disease: A Systematic Narrative Review.
Yang CH; Lin DY; Lin YS; Hsu CY; Tung MC; Tan KT; Ou YC
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614220
[TBL] [Abstract][Full Text] [Related]
16. Conservative Therapy for Peyronie's Disease: a Contemporary Review of the Literature.
Yousif A; Natale C; Hellstrom WJG
Curr Urol Rep; 2021 Jan; 22(2):6. PubMed ID: 33420664
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in managing Peyronie's disease.
Babu A; Kayes O
F1000Res; 2020; 9():. PubMed ID: 32518629
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive therapies for Peyronie's disease: the current state of the art.
Farrell MR; Ziegelmann MJ; Levine LA
Transl Androl Urol; 2020 Mar; 9(Suppl 2):S269-S283. PubMed ID: 32257868
[TBL] [Abstract][Full Text] [Related]
19. Laser Therapy for Peyronie's Disease: A Randomized Control Double-Blind Pilot Study.
Allameh F; Razzaghi M; Rayegani SM; Fallah-Karkan M; Ranjbar A; Rahavian A; Javadi A; Ghiasy S; Razzaghi Z
J Lasers Med Sci; 2019; 10(Suppl 1):S37-S42. PubMed ID: 32021671
[No Abstract] [Full Text] [Related]
20. Medical Management of Peyronie's Disease: Review of the Clinical Evidence.
Teloken P; Katz D
Med Sci (Basel); 2019 Sep; 7(9):. PubMed ID: 31540526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
